In 2019 Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR). The Syndicate recently expanded welcoming LifeArc in a tripartite managing partnership. The CF Syndicate in AMR is a cross-sector initiative which brings together leading experts in CF/AMR from industry, academia and the clinic together with people with CF.
Company Details
- Founded
- 2019
- Address
- Block 35, Alderley Park, Macclesfield,cheshire Sk10 4zf,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cfamr.org.uk/
- Keywords
- Adaptimmune.
- HQ
- Macclesfield, Cheshire
Cf Amr Syndicate Questions
Cf Amr Syndicate's website is https://cfamr.org.uk/
Cf Amr Syndicate's LinkedIn profile is https://uk.linkedin.com/company/cf-amr-syndicate
Cf Amr Syndicate's industry is
Biotechnology Research
Cf Amr Syndicate's top competitors are
Pace-Amr,
Eyebio,
Perspectum Ltd,
Cystic Fibrosis Trust,
Medicines Discovery Catapult,
Lifearc,
Vitarka Therapeutics,
Adaptimmune,
First Create The Media,
Ambrose Healthcare.
Cf Amr Syndicate's categories are Biotechnology Research
Cf Amr Syndicate's founding year is 2019
